Microbiota-Directed Therapies for the Treatment of Small Intestinal Bacterial Overgrowth: A Systematic Review and Meta-Analysis
Small intestinal bacterial overgrowth (SIBO) is characterized by an excessive proliferation of bacteria within the small intestine, resulting in chronic gastrointestinal symptoms, impaired quality of life, and frequent recurrence. Although rifaximin remains the cornerstone of treatment, increasing interest has focused...